VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,299,000 | -17.2% | 300,000 | 0.0% | 0.35% | -18.8% |
| Q2 2017 | $5,190,000 | +20.6% | 300,000 | -23.1% | 0.43% | -22.8% |
| Q1 2017 | $4,302,000 | -45.9% | 390,000 | +875.0% | 0.56% | +6.7% |
| Q1 2015 | $7,945,000 | -38.3% | 40,000 | -55.6% | 0.52% | -30.4% |
| Q4 2014 | $12,880,000 | +9.1% | 90,000 | 0.0% | 0.75% | +48.5% |
| Q3 2014 | $11,808,000 | +4.0% | 90,000 | 0.0% | 0.50% | +26.9% |
| Q2 2014 | $11,351,000 | – | 90,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |